|
|
ASH 2011: Dr. Ludwig - Serum Heavy/Light Chain and Free Light Chain Measurements Provide Prognostic Information, Allow Creation of a Prognostic Model and Identify Clonal Changes (clonal tiding) Through the Course of Multiple Myeloma (MM).
Heinz Ludwig, MD
Wilhelminenhospital
Vienna, Austria
|
|
|